EMEA Solid Oral Veterinary Excipients Market – Industry Trends and Forecast to 2031

EMEA Solid Oral Veterinary Excipients Market, By Functionality (Binders, Fillers and Diluents, Bulking Agents, Disintegrants, Lubricants, Coating Agents, Flavoring Agents, Colorants, Buffering Agents, and Others), Origin Type (Organic Chemicals and Inorganic Chemicals), Formulation (Tablets, Capsule, and Others), Animal (Farm Animal and Pet Animal), Application (Anti-Infectives, Anti-Inflammatory Drugs, Nutritional Supplements, and Others), Distribution Channel (Direct Tender, Retail Sales, and Others) – Industry Trends and Forecast to 2031.

EMEA Solid Oral Veterinary Excipients Market Analysis and Size

The EMEA solid oral veterinary excipients market has witnessed steady growth in recent years, driven by increasing consumer awareness of animal health and wellness, rising demand for dietary supplements for animals and for pharmaceutical and nutraceutical formulation advancements. Excipients are crucial in developing solid oral dosage forms, influencing product’s stability, bioavailability, and overall performance.

Some of the key factors contributing to the market growth include the increasing chronic diseases in animals, the growing health-conscious among consumer base, and the surge in lifestyle-related health issues even in animals, which has fueled the demand for veterinary supplements. Regulatory initiatives and standards in the EMEA region also play a vital role in shaping the market landscape, with manufacturers focusing on compliance with quality and safety regulations. However, the market faces challenges such as stringent regulatory requirements and the need for continuous innovation.

The EMEA solid oral veterinary excipients market is expected to reach USD 300,011.11 thousand by 2031 from USD 187,632.69 thousand in 2023, growing with a CAGR of 6.2% in the forecast period of 2024 to 2031.

Market Definition                                                                                                                                   

Solid oral veterinary excipients are inert substances incorporated into pharmaceutical formulations designed for oral administration to animals. These excipients play a crucial role in the overall composition of solid dosage forms such as tablets, capsules, powders, or granules, supporting the stability, bioavailability, and palatability of the medication. Common solid oral veterinary excipients include fillers, binders, disintegrants, lubricants, and flavoring agents. Fillers, such as lactose or cellulose, contribute to the bulk of the formulation, while binders help in holding the ingredients together. Disintegrants assist in the breakup of the dosage form upon ingestion, facilitating drug release. Lubricants ensure smooth manufacturing processes and aid in the ease of swallowing for the animal.

EMEA Solid Oral Veterinary Excipients Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail below:

Drivers

• Rising Pet Ownership and Humanization of Pets

The rising trend in pet ownership, particularly in dogs and cats, has led to an increase in the overall pet population. Pet ownership is increasing due to a combination of factors such as the desire for companionship, health benefits, changing attitudes towards pets, and increased disposable income. Pets provide companionship and emotional support, which is especially important for people who live alone or have limited social interactions. Studies have shown that pet ownership can have numerous health benefits, including lower blood pressure, reduced stress levels, and improved mental health.

 Developing effective and palatable solid oral dosage forms for veterinary medicines requires suitable excipients. Excipients are inactive ingredients used alongside the active pharmaceutical ingredient (API) to form a stable and administrable drug product. The demand for well-formulated and easily administrable pet medications has likely contributed to the market growth. Europe has experienced a growing trend in pet ownership over the years. More people in European countries, including the U.K., Germany, France, and others, have been adopting pets, particularly dogs and cats. Shifts in lifestyle and demographics have contributed to the rise in pet ownership. Factors such as urbanization, smaller family sizes, and an aging population have led to an increased desire for companionship, driving people to bring pets into their homes.

Many pet owners treat their pets as integral members of the family, leading to a trend known as the "humanization" of pets. As a result, there is a willingness among pet owners to invest in quality healthcare for their animals, which includes medications administered in various forms, such as solid oral dosage forms. Hence, the rising pet ownership is driving the market growth in the forecast period.

• Rising Focus on Animal Health and Well-Being

As pet owners and livestock producers become more proactive in ensuring the health of animals, there is a growing trend toward preventive healthcare. Solid oral veterinary excipients play a crucial role in the formulation of preventive medications, such as vaccines and nutritional supplements, contributing to overall well-being. The willingness of pet owners to spend more on healthcare services and products for their animals is a driving factor for the growth of the veterinary pharmaceutical market. This includes medications administered through solid oral dosage forms, which offer convenience and ease of administration.

There is a growing awareness among pet owners and livestock producers about the importance of proper nutrition, regular veterinary care, and disease prevention. This increased awareness drives the demand for pharmaceutical products, and solid oral excipients facilitate the delivery of medications to animals. The focus on animal well-being extends to nutrition. Advances in pet nutrition contribute to the development of supplements and medications that address specific health concerns. Solid oral veterinary excipients play a role in formulating these products to ensure they meet the nutritional needs of animals.

The one health approach, recognizing the interconnectedness of human, animal, and environmental health, encourages collaborative efforts to improve the health of all species. Solid oral veterinary excipients contribute to the success of one health initiatives by supporting effective veterinary medication administration. Hence, the rising focus on animal health and well-being is propelling the market growth in the forecast period.

Opportunity

• Technological Advancements in Excipients Formulations

Continuous technological advancements in the field of excipients formulations for veterinary medications present a myriad of opportunities for pharmaceutical companies. Innovations include the development of taste-masking agents, sustained-release formulations, and enhanced palatability enhancers. These advancements aim to address challenges related to the palatability and administration of solid oral veterinary medications. Taste-masking agents can make medications more palatable for animals, ensuring easier administration and improved compliance. Sustained-release formulations offer controlled and prolonged release of active ingredients, enhancing the efficacy and duration of therapeutic effects. Improved palatability enhancers contribute to a more positive medication experience for animals.

The advent of technological breakthroughs provides companies with the capability to create veterinary medications that go beyond conventional standards. These advancements not only enhance effectiveness and convenience but also address the evolving needs of veterinarians and pet owners. This results in an improved overall user experience, as companies are empowered to develop medications that align more closely with the requirements of modern veterinary care.

Restraint/Challenge

• Strict Regulations over Approval of the Veterinary Excipients and Drugs

Regulatory agencies impose stringent evaluation processes to ensure the safety and efficacy of veterinary excipients and drugs. The thorough review, testing, and approval processes can be time-consuming, leading to delays in bringing new products to market. Regulatory agencies set high standards for the safety and efficacy of veterinary pharmaceuticals, including excipients. Meeting these criteria requires extensive testing and documentation, which may pose challenges for companies in terms of resources and expertise. Manufacturers must provide comprehensive documentation to demonstrate the safety and efficacy of their products. The need for meticulous record-keeping and adherence to regulatory guidelines can present challenges, especially for companies navigating complex regulatory landscapes in different regions.

Stringent regulations increase the risk of product rejections or recalls if the veterinary excipients or drugs do not meet the required standards. These events can have significant financial implications and damage the reputation of the companies involved, potentially slowing the growth of the market. Strict regulatory oversight may discourage innovation due to the perceived risks and costs associated with developing new veterinary excipients or drugs. This can result in a limited range of products available in the market, reducing diversity and potentially hindering market growth.

Excipients used in veterinary medicinal products are subject to scrutiny for their safety and functionality. The European pharmacopoeia provides standards for excipients, and their use must comply with relevant guidelines. Hence, strict regulations over the approval of veterinary excipients and drugs can pose obstacles and potentially restrain market growth.

Recent Developments      

• In June 2023, Ashland will join The University of Texas at Austin - College of Pharmacy and other pharmaceutical industry leaders of advanced extrusion technology at the Life Science Twin Screw Extrusion Workshop hosted by Leistritz Advanced Technologies Corp
• In December 2022, U.S. Food and Drug Administration accepted Soluplus branded excipient in its program to evaluate safety and acceptability of excipients for use in clinical trials, independent from a specific New Drug Application. This has helped the company to strengthen its product portfolio

EMEA Solid Oral Veterinary Excipients Market Scope

The EMEA solid oral veterinary excipients market is segmented into six notable segments based on functionality, origin type, formulation, animal, application, and distribution channel. The growth amongst these segments will help you analyze major growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Functionality

• Binders
• Fillers and Diluents
• Bulking Agents
• Disintegrants
• Lubricants
• Coating Agents
• Flavoring Agents
• Colorants
• Buffering Agents
• Others

On the basis of functionality, the market is segmented into binders, fillers and diluents, bulking agents, disintegrants, lubricants, coating agents, flavoring agents, colorants, buffering agents, and others.

Origin Type

• Organic Chemicals
• Inorganic Chemicals

On the basis of origin type, the market is segmented into organic chemicals and inorganic chemicals.

Formulation

• Tablets
• Capsule
• Others

On the basis of formulation, the market is segmented into tablets, capsule, and others.

Animal

• Farm Animal
• Pet Animal

On the basis of animal, the market is segmented into farm animal and pet animal.

Application

• Anti-Infectives
• Anti-Inflammatory Drugs
• Nutritional Supplements
• Others

On the basis of application, the market is segmented into anti-infectives, anti-inflammatory drugs, nutritional supplements, and others.

Distribution Channel

• Direct Tender
• Retail Sales
• Others

On the basis of distribution channel, the market is segmented into direct tender, retail sales, and others.

EMEA Solid Oral Veterinary Excipients Market Regional Analysis/Insights

The EMEA solid oral veterinary excipients market is analyzed, and market size insights and trends are provided by functionality, origin type, formulation, animal, application, and distribution channel, as referenced above.

The countries covered in the EMEA solid oral veterinary excipients market report are Germany, France, Italy U.K., Spain, Russia, Netherlands, Belgium, Switzerland, Turkey, Rest of Europe, South Africa, Saudi Arabia, U.A.E., Algeria, Oman, Kuwait, and Rest of Middle East and Africa and Pakistan.

Europe is expected to dominate the market due to the rising trend in pet ownership, particularly in dogs and cats which has led to an increase in the overall pet population.

The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of regional brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Competitive Landscape and EMEA Solid Oral Veterinary Excipients Market Share Analysis

The EMEA solid oral veterinary excipients market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, regional presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus on the market.

Some of the major players operating in the EMEA solid oral veterinary excipients market are JRS PHARMA, BASF Corporation, Ashland, Evonik Industries AG, COLORCON, Roquette Frères., Merck KGaA, Kerry., International Flavors & Fragrances Inc, Croda International Plc, SEPPIC, Pharmatrans-Sanaq AG, DFE Pharma, DuPont., Biogrund GmbH, Pet Flavors LLC, SPI Pharma, and MEGGLE GmbH & Co. KG, among others.